Area under the curve: Comparing the value of factor VIII replacement therapies in haemophilia A

INTRODUCTION: In factor VIII (FVIII) prophylaxis for haemophilia A, cost comparisons have used price per international unit (IU) based on the once reasonable assumption of equivalent outcome per IU. Now, with several extended half‐life (EHL) products available, new outcome‐oriented ways to compare p...

Descripción completa

Detalles Bibliográficos
Autores principales: Persson, Sofie, Berndt, Cecilia, Engstrand, Sara, Trinczek, Annegret, Carlsson, Katarina Steen, Berntorp, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098947/
https://www.ncbi.nlm.nih.gov/pubmed/36445343
http://dx.doi.org/10.1111/hae.14691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098947/
https://www.ncbi.nlm.nih.gov/pubmed/36445343
http://dx.doi.org/10.1111/hae.14691

Ejemplares similares